Skip to main content

Table 3 Correlations between neonatal abstinence syndrome and measures of adult opioid use stratified by density of buprenorphine-waivered physicians and outpatient treatment program client case load

From: A state-level study of opioid use disorder treatment access and neonatal abstinence syndrome

  Correlation (r; 95% CI) p-value
Above median number of buprenorphine waivered physicians per 100,000 population (n = 20)1
 Proportion of individuals with illicit drug dependence or abuse −0.04 (− 0.48–0.41) 0.86
 Rate of opioid prescribing 0.48 (0.03–0.75) 0.03
Below median number of buprenorphine waivered physicians per 100,000 population (n = 18)1
 Proportion of individuals with illicit drug dependence or abuse 0.73 (0.38–0.88) < 0.001
 Rate of opioid prescribing 0.39 (−0.10–0.72) 0.12
Above median number of clients in outpatient treatment program per 100,000 population (n = 20)1
 Proportion of individuals with illicit drug dependence or abuse 0.33 (−0.14–0.67) 0.16
 Rate of opioid prescribing 0.27 (−0.21–0.63) 0.26
Below median number of clients in outpatient treatment program per 100,000 population (n = 18)1
 Proportion of individuals with illicit drug dependence or abuse 0.59 (0.15–0.82) 0.01
 Rate of opioid prescribing 0.38 (−0.11–0.72) 0.12
  1. 1“High” is above whereas “low” is below the national median; where the national median density of buprenorphine-waivered physicians = 8 per 100,000 population and the national median density of clients in outpatient treatment programs = 75 per 100,000 population